Business Standard

Monday, December 23, 2024 | 06:23 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Dr Reddys Laboratories Share Price

Know More
BSENSE

1,341.60-0.85 (-0.06%)

04:01 PM, 23-Dec-2024

1,341.35-2.30 (-0.17%)

03:48 PM, 23-Dec-2024

BSE : 500124

NSE : DRREDDY

Sector : Health care

ISIN Code : INE089A01031

  • BSE
  • NSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: 23-Dec-2024 | 04:01 PM IST

Market Cap (₹ Cr)

1,11,943

Traded Value (₹ Cr)

8.42

Volume (Shares)

62,748

Face Value (₹)

1

52-Week High (₹)

1,420.20

52-Week High Date

21-Aug-2024

52-Week Low (₹)

1,094.88

52-Week Low Date

21-Dec-2023

All Time High (₹)

1,420.20

All Time High Date

21-Aug-2024

All Time Low (₹)

0.77

All Time Low Date

11-Jun-1990

Dr Reddys Laboratories Ltd

Dr Reddy's Laboratories Ltd (DRL) is an integrated global pharmaceutical company committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services &Active Ingredients Global Generics and Proprietary Products - Dr. Reddy's offers a portfolio of products and services including Active Pharmaceutical Ingredients (APIs) custom pharmaceutical services generics biosimilars and differentiated formulations. The company's major therapeutic areas of focus are gastrointestinal cardiovascular diabetology oncology pain management and dermatology. Dr. Reddy's operates in markets across the globe. Its major markets include - USA India Russ...
Read More

Dr Reddys Laboratories Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

1,11,922

EPS - TTM (₹) [C]

63.98

P/E Ratio (X) [C]

20.97

Face Value (₹) 1
Latest Dividend (%)800.00
Latest Dividend Date 16-Jul-2024
Dividend Yield (%) 0.60
Book Value Share (₹) [C]368.52
P/B Ratio (₹) [C]3.64

Funds Owning this Stock

Scheme Name Amount Invested (₹ Cr) No Of Shares Net Asset (%)
Nippon India Hybrid Bond Fund (G) 0.83 6,635 0.10
Nippon India Hybrid Bond Fund - Direct (G) 0.83 6,635 0.10

Research Reports

DateBrokerActionPrices(₹) Report
29-Jul-2024Edelweiss Securities Underperform 6,237
02-Apr-2024Share Khan Buy 6,537
30-Oct-2023Prabhudas Lilladher Reduce 5,300
26-May-2023Anand Rathi Not Rated -
12-May-2023Prabhudas Lilladher Reduce 4,500

Stock Strength

Today's Low/High (₹)

1,330.30

1,367.00

Week Low/High (₹)

1,243.25

1,369.00

Month Low/High (₹)

1,188.45

1,369.00

Year Low/High (₹)

1,094.24

1,421.00

All time Low/High (₹)

0.77

1,421.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week5.63%5.62%-3.92-3.71%
1 Month10.50%10.45%-0.73-0.64%
3 Month0.86%0.79%-7.52-8.43%
6 Month11.62%11.57%1.721.07%
1 Year19.05%19.17%10.4511.26%
3 Year42.90%42.85%37.0339.13%

Company Info

Company Information

Co-Chairman & Managing Directo : G V Prasad

Executive Chairman : K Satish Reddy

Independent Director : Shikha Sanjaya Sharma

Lead Independent Director : Leo Puri

Independent Director : K P Krishnan

Independent Director : Pennv Wan

Company Sec. & Compli. Officer : K Randhir Singh

Independent Director : Arun M. Kumar

Independent Director : Claudio Albrecht

Independent Director : Sanjiv Mehta

Independent Director : Alpna Seth

Registered Office: 8-2-337 Road No 3, Banjara Hills,Hyderabad,Telangana-500034 Ph: 91-40-49002900

Email:shares@drreddys.com; mail@drreddys.com

URL:http://www.drreddys.com

FAQs about Dr Reddys Laboratories Ltd

1. What's the Dr Reddys Laboratories Ltd share price today?
Dr Reddys Laboratories Ltd share price was Rs 1,341.60 at 04:01 PM IST on 23rd Dec 2024. Dr Reddys Laboratories Ltd share price was down by 0.06% from the previous closing price of Rs 1,342.45. Dr Reddys Laboratories Ltd share price trend:

  • Last 1 Month: Dr Reddys Laboratories Ltd share price moved up by 10.50% on BSE
  • Last 3 Months: Dr Reddys Laboratories Ltd share price moved up by 0.86% on BSE
  • Last 12 Months: Dr Reddys Laboratories Ltd share price moved up by 19.05% on BSE
  • Last 3 Years: Dr Reddys Laboratories Ltd price moved up by 42.90% on BSE


2. How can I quickly analyse the performance of the Dr Reddys Laboratories Ltd stock?
The performance of the Dr Reddys Laboratories Ltd stock can be quickly analysed on the following metrics:

  • The stock's PE is 20.97
  • Price to book value ratio is 3.64
  • Dividend yield of 0.60
  • The EPS (trailing 12 months) of the Dr Reddys Laboratories Ltd stock is Rs 63.98


3. What is the market cap of Dr Reddys Laboratories Ltd?
Dr Reddys Laboratories Ltd has a market capitalisation of Rs 1,11,943 crore.


4. What is Dr Reddys Laboratories Ltd's 52-week high/low share price?
The Dr Reddys Laboratories Ltd’s 52-week high share price is Rs 1,420.20 and 52-week low share price is Rs 1,094.88.


5. Is the Dr Reddys Laboratories Ltd profitable?
On a consolidated basis, Dr Reddys Laboratories Ltd reported a profit of Rs 1,882.10 crore on a total income of Rs 6,903.90 crore for the quarter ended 2024. For the year ended Sep 2024, Dr Reddys Laboratories Ltd had posted a profit of Rs 1,341.90 crore on a total income of Rs 8,351.80 crore.


6. Which are Dr Reddys Laboratories Ltd’s peers in the Health care sector?
Dr Reddys Laboratories Ltd’s top 5 peers in the Health care sector are Mankind Pharma, Cipla, Torrent Pharma., Dr Reddy's Labs, Lupin, Zydus Lifesci., Aurobindo Pharma.


7. Who owns how much in Dr Reddys Laboratories Ltd?
Key changes to the Dr Reddys Laboratories Ltd shareholding are as follows:

  • Promoter holding in Dr Reddys Laboratories Ltd has gone down to 26.64 per cent as of Sep 2024 from 26.65 per cent as of Dec 2023.